Drug-Induced Thrombosis—Experimental, Clinical, and Mechanistic Considerations
Open Access
- 1 February 2007
- journal article
- review article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 35 (2), 208-225
- https://doi.org/10.1080/01926230601156237
Abstract
Awareness of the dangers of drug-induced thrombosis has recently been heightened and led to demand for improved testing methodology. For example, reports indicating that some selective inhibitors of cyclooxygenase-2 (COX-2) increase the risk of myocardial infarction and atherothrombotic events caused the withdrawal of rofecoxib from global markets and the issuance of warnings concerning the usage of other COX-2 inhibitors. Drugs may exert a prothrombotic state by a variety of mechanisms–those affecting the vessel wall, the blood flow, and/or different blood constituents. Our review serves as an update to that of Gerhard Zbinden published in 1976 by presenting recently acquired data that more fully elucidate the different mechanisms by which drugs are believed to induce thrombogenic effects and discussing new methods used to detect these without losing sight of the classical pathology of thrombosis. We offer correlations between experimental findings and clinical data and conclude that, because drugs may induce a prothrombotic state by a variety of mechanisms, they should be tested for these using appropriate experimental methods and animal models.Keywords
This publication has 110 references indexed in Scilit:
- Portal vein thrombosis during antineoplastic chemotherapy in children: Report of five cases and review of the literatureEuropean Journal Of Cancer, 2004
- Two Cases of Deep Vein Thrombosis Associated with a Combined Paroxetine and Zotepine TherapyPharmacopsychiatry, 1997
- Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycinAnti-Cancer Drugs, 1993
- 5HT2-receptors and serotonin release: Their role in human platelet aggregationLife Sciences, 1993
- Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosisAmerican Journal of Hematology, 1988
- The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiologyInternational Journal of Cardiology, 1987
- Wirkung von Röntgenkontrastmitteln auf das Endothel der Vena cava der RatteRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1983
- Die Auswertung endothelschädigender Wirkungen verschiedener angiographischer Kontrastmittel an einem TiermodellRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1981
- Hyperosmolalität von Röntgenkontrastmitteln - ein Faktor für die Endothelschädigung?RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1981
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodJournal of Pharmacological Methods, 1980